Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT

BACKGROUND: Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is triggered by nCOV-19 adenovirus-vectored vaccines against SARS-CoV2. Pathogenesis has been mainly related to platelet activation via PF4-reactive antibodies that activate platelets and may cross-react with heparin. Data con...

Descripción completa

Detalles Bibliográficos
Autores principales: Myllylahti, Lasse, Pitkänen, Hanna, Magnani, Harry, Lassila, Riitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814786/
https://www.ncbi.nlm.nih.gov/pubmed/35120527
http://dx.doi.org/10.1186/s12959-021-00362-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814786/
https://www.ncbi.nlm.nih.gov/pubmed/35120527
http://dx.doi.org/10.1186/s12959-021-00362-y

Ejemplares similares